2Al-Batran S E,Jaeger D.Oxaliplatin,5-fluorouracil and leucovorin every two weeks in patients with advanced gastric cancer;preliminary results of a multicenter,phase Ⅱ study[J].Proc Am Soc Clin Oncol,2003,22:1128a
4De Gramont A, Krulik M, Cady J, et al. High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer.Eur J Cancer Clin Oncol, 1988, 24:1499-1503.
5Ajani JA. Current status of therapy for advanced gastric carcinoma.Oncology, 1998, 12:99-102.
6Raymond E, Charley SG, Taamma A, et al. Oxaliplatin: a review of preclinical and clinical studies. Ann Oncol, 1998, 9:1053-1071.
7De Gramont A, Figer A, Seymonr M, et al. Leucovorin and fluorouracil with or without oxaliplatin as frist-line treatment in advanced colorectal cancer. J Clin Oncol, 2000,18:2938-2947.
8De Gramont A, Bosset JF, Milan C, et al. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly highdose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer : a French intergroup study. J Clin Oncol,1997, 15:808-815.
9WHO. 1994 World Health Statistics Annual. Geneve: WHO, 1995 ,B4-B347.
10Limburg P, Qiao Y, Mark S, et al. Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China. J Natl Cancer.Inst, 2001,93:226-233.
